In screening for an endocrine tumor causing hypertension, which test measures metabolites of catecholamines?

In screening for an endocrine tumor causing hypertension, which test measures metabolites of catecholamines?

• A. Metanephrine
• B. Catecholamines
• C. Thyroglobulin
• D. Vanillylmandelic acid

Answer: (A)

In screening for an endocrine tumor that causes hypertension, the goal is to detect evidence of catecholamine turnover from a pheochromocytoma. Catecholamines are metabolized into metanephrines and then into other metabolites like vanillylmandelic acid. Measuring the metabolites directly provides a more stable and sensitive indicator of catecholamine production than measuring the catecholamines themselves, which can fluctuate with stress or other factors. Among the options, metanephrine levels best reflect ongoing catecholamine metabolism produced by the tumor, making this test the most reliable screening choice. Vanillylmandelic acid is another metabolite but is less sensitive and more prone to interference from diet and medications. Thyroglobulin is unrelated to catecholamine metabolism.

In screening for an endocrine tumor that causes hypertension, the goal is to detect evidence of catecholamine turnover from a pheochromocytoma. Catecholamines are metabolized into metanephrines and then into other metabolites like vanillylmandelic acid. Measuring the metabolites directly provides a more stable and sensitive indicator of catecholamine production than measuring the catecholamines themselves, which can fluctuate with stress or other factors. Among the options, metanephrine levels best reflect ongoing catecholamine metabolism produced by the tumor, making this test the most reliable screening choice. Vanillylmandelic acid is another metabolite but is less sensitive and more prone to interference from diet and medications. Thyroglobulin is unrelated to catecholamine metabolism.